Gastroparesis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to sign a consent form and agree to follow all study requirements for the full duration of the trial
- You are between 18 and 70 years old at the time of receiving the Enterra® stomach stimulation device
- You have been diagnosed with gastroparesis (delayed stomach emptying) caused by either an unknown reason or by diabetes
- You have had a stomach-emptying test using a specific egg-based meal within the last year, showing that your stomach empties food unusually slowly
- A doctor has confirmed your stomach lining looked normal on a camera test (endoscopy) within the last year
- Your symptoms of nausea are rated at a certain level of severity on average each week, and you are vomiting 5 or more times per week, based on a specific symptom scoring tool
Who may not be able to join:
- Your gastroparesis was caused by a previous stomach surgery (such as certain types of stomach or anti-reflux operations)
- You have had a previous procedure to widen or cut open the valve between your stomach and small intestine (confirm with trial site)
- You are currently pregnant, breastfeeding, or planning to become pregnant during the study
- You have an active H. pylori stomach infection
- You have significant liver damage, shown by abnormal liver blood test results
- Your stomach symptoms may be explained by another condition, such as gallbladder disease, irritable bowel syndrome, inflammatory bowel disease, celiac disease, liver or pancreatic disease, bowel blockage, or bacterial overgrowth in the small intestine
- You have serious heart or cardiovascular disease, cancer, or certain other significant health conditions (confirm with trial site)
- You are currently taking part in another clinical trial
- You use narcotic pain medications more than three days per week, or take certain other medications that affect how your gut moves, such as GLP-1 drugs (a type of diabetes or weight-loss medication)
- You use cannabis or cannabinoid products more than three days per week, or use more than 3 grams in total per week, or use it more than twice per day of use
- You have a history of a condition causing dizziness or fainting when standing up, such as POTS or low blood pressure when standing
- You found the stimulation test during the assessment process too uncomfortable to tolerate
- You have a medical condition that requires you to have MRI scans in a way that may not be compatible with the implanted device (confirm with trial site)
- A temporary version of the stomach stimulation device was previously tried and did not help your symptoms
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Awad, MD, PhD, Washington University School of Medicine
Phone: 855-768-3772
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Vomiting Absolute Frequency; Change in Nausea Severity Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.